| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $9,950,242 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K01DK133627 | Examining the role of locus coeruleus glucagon-like peptide-1 receptors infeeding behavior. | 001 | 4 | NIH | 1/16/2026 | $150,930 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM133600 | Repetitive sequences drive genome variation and plasticity | 000 | 7 | NIH | 1/7/2026 | $463,652 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM128635 | Mechanisms of coordinate gene regulation by transcription factors | 000 | 8 | NIH | 1/12/2026 | $404,595 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162154 | Mechanisms of translation response to stress | 000 | 1 | NIH | 2/13/2026 | $457,875 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM156397 | UBIQUITIN-PROTEASOME PATHWAY in HUMAN DISEASE | 000 | 2 | NIH | 1/15/2026 | $424,450 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AR085243 | Metabolomic Signatures of Alcohol Consumption and Risk of Knee Osteoarthritis | 000 | 2 | NIH | 2/6/2026 | $162,141 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS131661 | Transient Receptor Potential Melastatin 2 (TRPM2) in Ischemic Stroke | 000 | 3 | NIH | 12/23/2025 | $406,904 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 000 | 4 | NIH | 1/30/2026 | $454,846 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01MH085927 | Synaptic function of BK channel-interacting proteins | 000 | 15 | NIH | 1/6/2026 | $551,722 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 000 | 3 | NIH | 2/12/2026 | $507,162 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK134475 | Novel mechanisms of kidney inflammation and fibrosis | 000 | 4 | NIH | 12/17/2025 | $523,599 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK132059 | Importance of cell-matrix interactions in kidney repair after acute kidney injury | 000 | 4 | NIH | 12/19/2025 | $493,382 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 000 | 4 | NIH | 2/13/2026 | $497,480 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 000 | 3 | NIH | 1/9/2026 | $392,705 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 5 | NIH | 12/12/2025 | $387,625 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 000 | 4 | NIH | 1/31/2026 | $392,876 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 3 | NIH | 1/20/2026 | $677,618 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084992 | Role of NOTCH2 in Articular Inflammation | 000 | 2 | NIH | 2/12/2026 | $361,222 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 000 | 14 | NIH | 1/14/2026 | $483,019 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI187147 | The role of unanchored ubiquitin chains in non-canonical inflammasome signaling | 000 | 1 | NIH | 2/1/2026 | $523,037 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 000 | 4 | NIH | 12/17/2025 | $632,825 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K99DA062786 | Mechanisms of Action of Peer Recovery Support for People Receiving Opioid Use Disorder Treatment | 000 | 1 | NIH | 2/3/2026 | $191,700 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162332 | Cracking the tubulin code of cell migration | 000 | 1 | NIH | 2/12/2026 | $457,875 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30GM163345 | Investigating how splicing factor homeostasis shapes transcriptomes in pluripotency and differentiation | 000 | 1 | NIH | 2/1/2026 | $46,415 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U7701068 | Model State-Supported Area Health Education Centers | 02 | 23 | HRSA | 11/18/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H4B33384 | Poison Control Stabilization and Enhancement Program | 03 | 7 | HRSA | 2/5/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H4B33384 | Poison Control Stabilization and Enhancement Program | 02 | 7 | HRSA | 1/26/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H4B33384 | Poison Control Stabilization and Enhancement Program | 01 | 7 | HRSA | 12/9/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 000 | 4 | NIH | 1/8/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM118140 | Genomic Analysis of Nucleic Acid Transactions | 000 | 10 | NIH | 2/10/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R34MH129410 | Enhancing the Capacity of Pediatric Primary Care Providers: A Pilot Trial of Anxiety Action Plan | 000 | 3 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EB037174 | In situ formed microneedle-like depots for spatiotemporally controlled drug delivery | 000 | 1 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS111986 | Regulation of synaptic plasticity by BDNF-endocannabinoid interactions | 000 | 5 | NIH | 12/12/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS120556 | Combinatorial function of Foxp1/2/4 in Purkinje cell diversification and cerebellar development | 000 | 5 | NIH | 1/30/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL150362 | RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity | 000 | 5 | NIH | 12/8/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK129431 | Role of FGF23 in Bone, Kidney, Blood, Crosstalk in Sickle Cell Disease Mice | 000 | 4 | NIH | 1/12/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DE021103 | Modulated release of anti-senescence drugs to stimulate aged bone repair | 000 | 10 | NIH | 12/3/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI150919 | The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H79SM085080 | Center for the Treatment of Developmental Trauma Disorders | 001 | 4 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H79SM085111 | Center for Trauma Recovery and Juvenile Justice | 003 | 3 | SAMHSA | 2/11/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H79SM085080 | Center for the Treatment of Developmental Trauma Disorders | 000 | 4 | SAMHSA | 1/14/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H79SM085111 | Center for Trauma Recovery and Juvenile Justice | 002 | 3 | SAMHSA | 2/10/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H79SM085111 | Center for Trauma Recovery and Juvenile Justice | 001 | 3 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H79SM085111 | Center for Trauma Recovery and Juvenile Justice | 000 | 3 | SAMHSA | 1/14/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31AI178967 | Innate immune roles of glycoRNA | 000 | 2 | NIH | 12/29/2025 | -$27,826 |
| | 2026 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | T7330115 | Leadership Education in Neurodevelopmental and Related Disorders Training Program | 02 | 10 | HRSA | 11/20/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | UH3DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 000 | 6 | NIH | 2/10/2026 | $0 |
| | 2026 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM138319 | Scope and mechanism of coordinated alternative splicing and alternative polyadenylation | 000 | 6 | NIH | 12/16/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21MH130902 | Role of COP1 in dendritic spines, cognition and stress resilience | 000 | 2 | NIH | 1/23/2026 | $0 |
|
